These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Implant wear induces inflammation, but not osteoclastic bone resorption, in RANK(-/-) mice. Ren W; Wu B; Peng X; Hua J; Hao HN; Wooley PH J Orthop Res; 2006 Aug; 24(8):1575-86. PubMed ID: 16779834 [TBL] [Abstract][Full Text] [Related]
10. Molecular basis of osteoclastogenesis induced by osteoblasts exposed to wear particles. Granchi D; Amato I; Battistelli L; Ciapetti G; Pagani S; Avnet S; Baldini N; Giunti A Biomaterials; 2005 May; 26(15):2371-9. PubMed ID: 15585240 [TBL] [Abstract][Full Text] [Related]
11. Effects of polyethylene and TiAlV wear particles on expression of RANK, RANKL and OPG mRNA. Baumann B; Rader CP; Seufert J; Nöth U; Rolf O; Eulert J; Jakob F Acta Orthop Scand; 2004 Jun; 75(3):295-302. PubMed ID: 15260421 [TBL] [Abstract][Full Text] [Related]
12. The influence of alumina and ultra-high molecular weight polyethylene particles on osteoblast-osteoclast cooperation. Granchi D; Ciapetti G; Amato I; Pagani S; Cenni E; Savarino L; Avnet S; Peris JL; Pellacani A; Baldini N; Giunti A Biomaterials; 2004 Aug; 25(18):4037-45. PubMed ID: 15046894 [TBL] [Abstract][Full Text] [Related]
13. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. Ulrich-Vinther M; Carmody EE; Goater JJ; S balle K; O'Keefe RJ; Schwarz EM J Bone Joint Surg Am; 2002 Aug; 84(8):1405-12. PubMed ID: 12177271 [TBL] [Abstract][Full Text] [Related]
14. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis. Sabokbar A; Kudo O; Athanasou NA J Orthop Res; 2003 Jan; 21(1):73-80. PubMed ID: 12507582 [TBL] [Abstract][Full Text] [Related]
15. Association between UHMWPE particle-induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt-1 in vivo. Ren WP; Markel DC; Zhang R; Peng X; Wu B; Monica H; Wooley PH Biomaterials; 2006 Oct; 27(30):5161-9. PubMed ID: 16814378 [TBL] [Abstract][Full Text] [Related]
16. The decrease of particle-induced osteolysis after a single dose of bisphosphonate. von Knoch M; Wedemeyer C; Pingsmann A; von Knoch F; Hilken G; Sprecher C; Henschke F; Barden B; Löer F Biomaterials; 2005 May; 26(14):1803-8. PubMed ID: 15576154 [TBL] [Abstract][Full Text] [Related]
18. The effectiveness of polyethylene versus titanium particles in inducing osteolysis in vivo. von Knoch M; Jewison DE; Sibonga JD; Sprecher C; Morrey BF; Loer F; Berry DJ; Scully SP J Orthop Res; 2004 Mar; 22(2):237-43. PubMed ID: 15013080 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of crude bone morphogenetic protein-induced new bone formation and normalization of endochondral ossification by bisphosphonate treatment in osteoprotegerin-deficient mice. Tabuchi M; Miyazawa K; Kimura M; Maeda H; Kawai T; Kameyama Y; Goto S Calcif Tissue Int; 2005 Oct; 77(4):239-49. PubMed ID: 16193235 [TBL] [Abstract][Full Text] [Related]
20. Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK. Théoleyre S; Kwan Tat S; Vusio P; Blanchard F; Gallagher J; Ricard-Blum S; Fortun Y; Padrines M; Rédini F; Heymann D Biochem Biophys Res Commun; 2006 Aug; 347(2):460-7. PubMed ID: 16828054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]